IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review

IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
IQVIA Holdings Inc (IQVIA) provides information, novel technological solutions and clinical research services. The company harnesses data and science to offer an array of solutions to healthcare companies, which include clinical development, commercialization and technologies that result in significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behavior and scientific advances. IQVIA serves medical device, biotech and pharmaceutical companies; government agencies, medical researchers, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, and Africa. IQVIA is headquartered in Durham, North Carolina, the US.

IQVIA Holdings Inc Key Recent Developments

May 02,2024: IQVIA Reports First-Quarter 2024 Results
Feb 14,2024: IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
Jan 24,2024: IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
Nov 21,2023: IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
IQVIA Holdings Inc - Key Facts
IQVIA Holdings Inc - Key Employees
IQVIA Holdings Inc - Key Employee Biographies
IQVIA Holdings Inc - Major Products and Services
IQVIA Holdings Inc - History
IQVIA Holdings Inc - Company Statement
IQVIA Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
IQVIA Holdings Inc - Business Description
Business Segment: Contract Sales & Medical Solutions
Overview
Performance
Business Segment: Research & Development Solutions
Overview
Performance
Business Segment: Technology & Analytics Solutions
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe and Africa
Performance
IQVIA Holdings Inc - Corporate Strategy
IQVIA Holdings Inc - SWOT Analysis
SWOT Analysis - Overview
IQVIA Holdings Inc - Strengths
IQVIA Holdings Inc - Weaknesses
IQVIA Holdings Inc - Opportunities
IQVIA Holdings Inc - Threats
IQVIA Holdings Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
IQVIA Holdings Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 02, 2024: IQVIA Reports First-Quarter 2024 Results
Feb 14, 2024: IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
Jan 24, 2024: IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
Nov 21, 2023: IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023
Nov 14, 2023: IQVIA Announces Offering of Senior Secured Notes
Nov 01, 2023: IQVIA Reports Third-Quarter 2023 Results
Oct 05, 2023: Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science
Oct 02, 2023: IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
Sep 05, 2023: IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
Jun 27, 2023: IQVIA Wins Prestigious “Best AI-Based Solution for Healthcare” Award in 2023 Artificial Intelligence Breakthrough Awards
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
IQVIA Holdings Inc, Key Facts
IQVIA Holdings Inc, Key Employees
IQVIA Holdings Inc, Key Employee Biographies
IQVIA Holdings Inc, Major Products and Services
IQVIA Holdings Inc, History
IQVIA Holdings Inc, Other Locations
IQVIA Holdings Inc, Subsidiaries
IQVIA Holdings Inc, Key Competitors
IQVIA Holdings Inc, Ratios based on current share price
IQVIA Holdings Inc, Annual Ratios
IQVIA Holdings Inc, Annual Ratios (Cont...1)
IQVIA Holdings Inc, Annual Ratios (Cont...2)
IQVIA Holdings Inc, Interim Ratios
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
IQVIA Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
IQVIA Holdings Inc, Performance Chart (2019 - 2023)
IQVIA Holdings Inc, Ratio Charts
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings